Graham Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Buy |
+25,681
| New | +$208K | ﹤0.01% | 1081 |
|
|
2024
Q1 | – | Sell |
-22,066
| Closed | -$134K | – | 1026 |
|
|
2023
Q4 | $134K | Buy |
+22,066
| New | +$134K | ﹤0.01% | 866 |
|
|
2023
Q3 | – | Sell |
-30,092
| Closed | -$93.3K | – | 986 |
|
|
2023
Q2 | $93.3K | Buy |
30,092
+9,046
| +43% | +$28K | ﹤0.01% | 882 |
|
|
2023
Q1 | $29.3K | Sell |
21,046
-513,783
| -96% | -$714K | ﹤0.01% | 1002 |
|
|
2022
Q4 | $1.06M | Buy |
+534,829
| New | +$1.06M | 0.03% | 497 |
|
|
2022
Q2 | – | Sell |
-103,532
| Closed | -$431K | – | 981 |
|
|
2022
Q1 | $431K | Buy |
+103,532
| New | +$431K | 0.01% | 596 |
|